Locate Bio’s Chondro3 Graft Granted FDA Breakthrough Device Designation

Locate Bio Chondro3 Plug

Locate Bio was granted Breakthrough Device designation by FDA for Chondro3, currently in development as a biomimetic graft for osteochondral lesions.

This is the company's second FDA Breakthrough Device designation granted in 2021. In January, the company was granted a Breakthrough Device designation for CognitOss, an investigational...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us